Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which predicts that the Protein Therapeutic Market will grow from US$57 Billion in 2006 at a CAGR of 12.83% till 2010.
The report, "Global Protein Therapeutics Market Analysis", which is available at http://www.piribo.com/
The study finds that US is the largest market for therapeutic proteins in the world followed by Europe and Japan. It says insurance reimbursement is a major factor that decides the success of protein therapeutics.
Authors of the report point out that the global protein therapeutics market will also be facing numerous challenges. For instance, until recently, protein therapeutics faced little generic threat, but changing regulations will allow generics which are already present in Europe and Asia, to be introduced in US by 2009. Another such challenge is that a high rate of failure in phase-3 clinical trials coupled with the high rate of expenditure, affects the market.
Analysts say that the market is presently dominated by monoclonal antibodies, and forecast that this segment will see double-digit growth. Additionally, insulin, interferon Beta, G-CSF and coagulation factors are also exhibiting double-digit growth rates. It highlights that one of the biggest opportunity areas in the Protein Therapeutics Market will be in the field of biogenerics, which is expected to create a multi-billion dollar market in future.
“Global Protein Therapeutics Market Analysis” is available in pdf format from Piribo. For more information, go to: http://www.piribo.com/
Piribo product ID: RCS290
